Ekso Bionics Holdings, Inc. financial data

Symbol
EKSO on Nasdaq
Location
101 Glacier Point, Suite A, San Rafael, CA
State of incorporation
NV
Fiscal year end
December 31
Former names
PN Med Group Inc (to 12/31/2013)
Latest financial report
10-Q - Q3 2024 - Oct 28, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 263 % -8.86%
Quick Ratio 65.8 % +10.1%
Debt-to-equity 113 % +42.1%
Return On Equity -83.1 % -9.32%
Return On Assets -39 % +7.86%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22M shares +54.5%
Common Stock, Shares, Outstanding 22M shares +54.5%
Entity Public Float 18.7M USD -0.77%
Common Stock, Value, Issued 22K USD +57.1%
Weighted Average Number of Shares Outstanding, Basic 20.3M shares +44.3%
Weighted Average Number of Shares Outstanding, Diluted 20.3M shares +44.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 4.34M USD -6.72%
Selling and Marketing Expense 7.41M USD -12.2%
General and Administrative Expense 9.1M USD -20.2%
Operating Income (Loss) -11.7M USD +27.5%
Nonoperating Income (Expense) 548K USD -41.5%
Net Income (Loss) Attributable to Parent -11.1M USD +26.6%
Earnings Per Share, Basic -0.65 USD/shares +42%
Earnings Per Share, Diluted -0.65 USD/shares +42%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.29M USD -16.6%
Accounts Receivable, after Allowance for Credit Loss, Current 6.96M USD +18.6%
Inventory, Net 5.03M USD -8.31%
Assets, Current 21.1M USD -5.8%
Property, Plant and Equipment, Net 1.63M USD -22%
Operating Lease, Right-of-Use Asset 891K USD -15.4%
Intangible Assets, Net (Excluding Goodwill) 4.66M USD -6.24%
Goodwill 431K USD 0%
Other Assets, Noncurrent 531K USD +90.3%
Assets 29.2M USD -6.33%
Accounts Payable, Current 1.81M USD -27.7%
Employee-related Liabilities, Current 1.41M USD -8.3%
Accrued Liabilities, Current 1.98M USD -5.77%
Contract with Customer, Liability, Current 2.04M USD +24.7%
Liabilities, Current 7.51M USD -4.19%
Contract with Customer, Liability, Noncurrent 1.97M USD -4.51%
Operating Lease, Liability, Noncurrent 556K USD -31.9%
Other Liabilities, Noncurrent 165K USD +68.4%
Liabilities 14.3M USD -9.97%
Accumulated Other Comprehensive Income (Loss), Net of Tax 12K USD -98.4%
Retained Earnings (Accumulated Deficit) -247M USD -4.72%
Stockholders' Equity Attributable to Parent 14.9M USD -2.54%
Liabilities and Equity 29.2M USD -6.33%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.47M USD +17.8%
Net Cash Provided by (Used in) Financing Activities 3.66M USD
Net Cash Provided by (Used in) Investing Activities -8K USD +81%
Common Stock, Shares Authorized 141M shares 0%
Common Stock, Shares, Issued 22M shares +54.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 161K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.29M USD -16.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 48K USD +2.13%
Deferred Tax Assets, Valuation Allowance 58.3M USD +7.91%
Operating Lease, Liability 990K USD -15.2%
Depreciation 414K USD +79.2%
Payments to Acquire Property, Plant, and Equipment 8K USD -81%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -11.9M USD +25.5%
Lessee, Operating Lease, Liability, to be Paid 1.08M USD -17.9%
Property, Plant and Equipment, Gross 5.17M USD -8.86%
Operating Lease, Liability, Current 434K USD +23.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 431K USD +3.86%
Lessee, Operating Lease, Liability, to be Paid, Year One 484K USD +11.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 93K USD -38.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 41K USD -88.7%
Deferred Tax Assets, Operating Loss Carryforwards 52.4M USD +7.41%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 1.89M USD +165%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Additional Paid in Capital 262M USD +4.58%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 406K USD -1.93%
Share-based Payment Arrangement, Expense 1.55M USD -33%
Interest Expense 247K USD +2.49%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%